Adcock Ingram delisting from the JSE is confirmed for November 11. Learn about the impact of the Natco Pharma acquisition.
Adcock Ingram Delisting After Natco Acquisition
Original Article by Jacqueline Mackenzie | Business Day | 27 October 2025
Adcock Ingram delisting from the JSE is confirmed for November 11. Learn about the impact of the Natco Pharma acquisition.
More Posts
Compounded semaglutide appeal dismissed
A court has upheld restrictions on compounded semaglutide at iDexis while regulatory investigations continue.
Read more...
WHO’s Africa Chief Urges Action, Not Talk, on Primary Healthcare
WHO Africa director Mohamed Janabi urged governments to finance primary healthcare and pursue health sovereignty.
Read more...
Unpaid specialist training strains SA doctors
Unpaid specialist training is growing in South Africa as scarce funded posts leave doctors working without salaries.
Read more...